This is an in-house translation of the Swedish press release “Ny metod för att återbygga käkben hos implantatpatienter kliniskt bevisad”, dated March 15, 2011. In the event of any discrepancies between the Swedish and the English versions, the Swedish version shall prevail.
Press release March 15, 2011
In a case study recently published in JOMI (The International Journal of Oral & Maxillofacial Implants), researchers have succeeded in rebuilding jawbone resorbed due to peri-implantitis (inflammation with concurrent bone loss around dental implants) with titanium. The unique evidence is first in its kind to prove implant stabilization in patients afflicted with peri-implantitis.
”Ten years after implant treatment, about 15-20 % of the patients have infections around one or several implants. If not treated, the inflammation may lead to loss of the infected implant. Dr Wohlfahrt’s results are very positive and indicate a possibility to treat such infections”, says Stefan Renvert, Professor of Oral Health Sciences at Kristianstad University.
”Dr Wohlfahrt’s case study is unique and proves for the first time that jawbone resorbed around a titanium implant as a consequence of inflammation (peri-implantitis) can be rebuilt with titanium”, says Björn Sellert, CEO Tigran Technologies AB.
Tigran Technologies is the company behind the small titanium granules that act as a scaffold for the body’s bone cells when the jawbone needs reinforcement or regeneration. The company sees a large potential for the product that can be used for rebuilding jawbone within several dental applications.
“Treating patients afflicted by bone loss with titanium instead of other products available on the market such as bone regeneratives based on bovine materials has several advantages. Firstly, because titanium is fully non-resorbable, it allows for predictable and long-term results. Secondly, titanium is preferable from an ethical point of view because avoidance of using animal-based products. Furthermore, titanium is a thoroughly tried-out and well-documented material used in the human body for over 40 years”, says Björn Sellert.
A main study within peri-implantitis on 32 patients has been submitted for publication and is expected to be published during this year. Within the sinus lift area (bone regeneration in the upper jaw to install dental implants), very positive five year data of a study was recently presented. Furthermore, additional international multicenter studies are ongoing to further prove titanium’s capacity in various dental bone regeneration applications.
Link to abstract for “Micro CT and Human Histological Analysis of a Peri-Implant Osseous Defect Grafted with Porous Titanium Granules: A Case Report”: http://www.quintpub.com/journals/omi/abstract.php?iss2_id=912&article_id=10448
For more information, please contact Björn Sellert, CEO Tigran Technologies AB:
T: +46 768 60 77 10
E: b.sellert@tigran.se
W: www.tigran.se
About Tigran Technologies AB
Tigran Technologies AB (publ) is a dental sales- and development company based in Sweden. Tigran offers a system for bone regeneration and implant fixation in the mouth. The technology is based on porous titanium grains acting as climbing frame for the body’s bone cells in the process to rebuild jawbone in order to place and stabilize implants and prevent further bone loss. Tigran also develops instruments for an optimized treatment and increased patient comfort in dental bone regeneration procedures.
Tigran runs an extensive development program and has a number of published, submitted and on-going experimental and clinical studies. The company’s products, methods and technologies are covered by a strong intellectual property portfolio. The products are CE-marked. Tigran’s products are sold through selected distributors and through own sales force. “Tigran” is a registered trademark of Tigran Technologies AB.
